Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Garcia

Showing results (271-280 of 328) with videos related to

Pageof 33
Sort By:
Biological Psychiatry|July 17, 2024
A Novel Role for the Histone Demethylase JMJD3 in Mediating Heroin-Induced Relapse-Like BehaviorsSwarup Mitra, Craig T Werner, Treefa Shwani, et al.
ACS Chemical Neuroscience|December 12, 2018
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective InhibitorsObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Journal of Medicinal Chemistry|March 18, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's diseaseObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
NPJ Parkinson'S Disease|February 11, 2026
Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's diseaseJulia Chocarro, Sergio Marana, Maria Espelosin, et al.
The Lancet. Healthy Longevity|September 2, 2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort studyCatarina Tristão-Pereira, Valentin Fuster, Belen Oliva, et al.
Plos One|May 26, 2016
Von Willebrand Factor Gene Variants Associate with Herpes simplex EncephalitisNada Abdelmagid, Biborka Bereczky-Veress, Santosh Atanur, et al.
ACS Chemical Neuroscience|August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity ProfilesObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Heart Journal. Cardiovascular Imaging|March 5, 2019
Mid-term outcome of severe tricuspid regurgitation: are there any differences according to mechanism and severity?Ciro Santoro, Alvaro Marco Del Castillo, Ariana González-Gómez, et al.
European Geriatric Medicine|March 27, 2025
Appropriateness of antibiotic use in nursing homes for suspected urinary tract infections: comparison across five European countriesMatilde Bøgelund Hansen, Jesper Lykkegaard, Malene Plejdrup Hansen, et al.
Studies in Health Technology and Informatics|May 25, 2022
Making EHRs Trustable: A Quality Analysis of EHR-Derived Datasets for COVID-19 ResearchMiguel Pedrera-Jimenez, Noelia Garcia-Barrio, Paula Rubio-Mayo, et al.
Pageof 33

Showing results (271-280 of 328) with videos related to

Sort By:
Pageof 33
Biological Psychiatry|July 17, 2024
A Novel Role for the Histone Demethylase JMJD3 in Mediating Heroin-Induced Relapse-Like BehaviorsSwarup Mitra, Craig T Werner, Treefa Shwani, et al.
ACS Chemical Neuroscience|December 12, 2018
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective InhibitorsObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Journal of Medicinal Chemistry|March 18, 2018
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's diseaseObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
NPJ Parkinson'S Disease|February 11, 2026
Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's diseaseJulia Chocarro, Sergio Marana, Maria Espelosin, et al.
The Lancet. Healthy Longevity|September 2, 2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort studyCatarina Tristão-Pereira, Valentin Fuster, Belen Oliva, et al.
Plos One|May 26, 2016
Von Willebrand Factor Gene Variants Associate with Herpes simplex EncephalitisNada Abdelmagid, Biborka Bereczky-Veress, Santosh Atanur, et al.
ACS Chemical Neuroscience|August 24, 2019
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity ProfilesObdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, et al.
European Heart Journal. Cardiovascular Imaging|March 5, 2019
Mid-term outcome of severe tricuspid regurgitation: are there any differences according to mechanism and severity?Ciro Santoro, Alvaro Marco Del Castillo, Ariana González-Gómez, et al.
European Geriatric Medicine|March 27, 2025
Appropriateness of antibiotic use in nursing homes for suspected urinary tract infections: comparison across five European countriesMatilde Bøgelund Hansen, Jesper Lykkegaard, Malene Plejdrup Hansen, et al.
Studies in Health Technology and Informatics|May 25, 2022
Making EHRs Trustable: A Quality Analysis of EHR-Derived Datasets for COVID-19 ResearchMiguel Pedrera-Jimenez, Noelia Garcia-Barrio, Paula Rubio-Mayo, et al.
Pageof 33